a Department of Neurology, b Department of Neurophysiology, The Walton Centre for Neurology and Neurosurgery, Rice Lane, Liverpool L9 1AE, UK Dr Malcolm J Steiger, The Walton Centre for Neurology and ...

Department of Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand Correspondence to: R J Siegert Rehabilitation Teaching and Research Unit, ...

Background Few studies have investigated patient-reported non-motor outcomes after stroke in young adults. We aimed to assess ...

Background Stroke remains a significant global health challenge, especially in low- and middle-income countries, despite ...

Over 10 million people with epilepsy qualify as surgical candidates worldwide, with 1.4 million new potential surgical ...

Acquired cerebellar ataxia has been described with hypothyroidism, and is typically reversible by thyroid hormone replacement therapy. The cerebellar dysfunction has been attributed to metabolic and ...

Background Epilepsy affects 22.2% of people with intellectual disability compared with 1% of the general population. This study aims to identify characteristics associated with epilepsy-caused deaths ...

In 1997, the neurologist Rajendra Kale stated in the British Medical Journal ‘The history of epilepsy can be summarised as 4000 years of ignorance, superstition, and stigma followed by 100 years of ...

Associate Professor D R Royall, Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78284–7792, USA. Telephone 001 210 567 ...

1 Department of Neurology, University of Virginia School of Medicine, Charlottesville, USA 2 Department of Health Evaluation Sciences, University of Virginia School of Medicine Correspondence to: Dr G ...

Objective: to study the underlying cognitive deficits influencing a stroke patient’s ability to relearn to dress. The aim was to investigate how recovery had occurred and whether the nature of ...

From 1979-85, 2435 patients with a transient ischaemic attack or minor ischaemic stroke were randomly allocated to receive long term "blind" treatment with aspirin 600 mg twice daily (n = 815), ...